Indices
indexlast change%
Dow Jones
SP 500
NASDAQ
VIX
VIX Tail
All Ords
US 10 Year
US 2 Year
indexlast change%
Bitcoin
Ethereum
AUD/USD
GBP/USD
EURUSD
JPYUSD
Commodity
indexlast change%
Brent Cruide
Silver
GOLD
Top news stories
News date
Aqua Metals Signs Definitive Agreement with ACME Metal Enterprise to Deploy AquaRefining Technology in Taiwan
Company Preparing to Ship AquaRefining Equipment for First Deployment Company Preparing to Ship AquaRefining Equipment for First Deployment
globenewswire
Thu 12:01
AQMS US
Arbutus to Report Second Quarter 2021 Financial Results and Provide Corporate Update
WARMINSTER, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced that it has scheduled its second quarter 2021 financial results and corporate update for Thursday, August 5, 2021. The schedule for the press release and conference call/webcast are as follows:
globenewswire
Thu 12:00
ABUS US
CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based on its Probody technology platform, today announced that it will report second quarter 2021 financial results onThursday, August 5, 2021, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at5:00 p.m. ET/2:00 p.m. PTto discuss the results and provide a corporate update.
globenewswire
Thu 12:00
CTMX US
Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating Binding and Neutralization of the SARS-CoV-2 Delta Variant by Lead Anti-COVID-19 Antibody, AUG-3387
Data Shows AUG-3387 Neutralizes SARS-CoV-2 Delta Variant in Infective Assays
globenewswire
Thu 12:00
TFFP US
: CyrusOne double upgraded to outperform from underperform at Raymond James
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
marketwatch
Thu 11:56
CONE US
: Altice USA downgraded to outperform from strong buy at Raymond James
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
marketwatch
Thu 11:53
ATUS US
$CTXS - Citrix slumps after Q2 revenue misses, lowered full-year outlook https://t.co/g1ujYiql4r
$CTXS - Citrix slumps after Q2 revenue misses, lowered full-year outlook https://t.co/g1ujYiql4r
@MarketCurrents
Thu 11:35
CTXS US
Watch these movies & shows before they leave Netflix this week https://t.co/eiLajVhc09
Watch these movies & shows before they leave Netflix this week https://t.co/eiLajVhc09
@TeenVogue
Thu 11:35
NFLX US
Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, August 5, 2021, 10:00 a.m. ET Conference Call and Live Audio Webcast Scheduled for Thursday, August 5, 2021, 10:00 a.m. ET
globenewswire
Thu 11:33
SLRX US
$BPMC - Blueprint Medicines  EPS misses by $0.05, beats on revenue https://t.co/7aIRb4cQHn
$BPMC - Blueprint Medicines  EPS misses by $0.05, beats on revenue https://t.co/7aIRb4cQHn
@MarketCurrents
Thu 11:08
BPMC US
: Altria Q2 cigarettes shipments up 1.4% to 25.31 bln sticks
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
marketwatch
Thu 11:05
MO US
Provention Bio to Report Second Quarter 2021 Financial Results on August 5, 2021
RED BANK, N.J., July 29, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its second quarter 2021 financial results on Thursday, August 5, 2021,...
prnewswire:443
Thu 11:00
PRVB US
OneWater Marine Inc. Announces Fiscal Third Quarter 2021 Results
Strong Execution Drove Significant Margin Expansion and Earnings Growth
globenewswire
Thu 11:00
ONEW US
Genocea Provides Second Quarter 2021 Corporate Update
GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues
globenewswire
Thu 11:00
GNCA US
Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a fully-integrated clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Companys second quarter 2021 financial results will be released on Thursday, August 5, 2021. Company management will host a conference call on Thursday, August 5, 2021 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.
globenewswire
Thu 11:00
CALA US
Chimerix to Report Second Quarter 2021 Financial Results and Provide an Operational Update on August 5, 2021
DURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that it will host a live conference call and audio webcast on Thursday, August 5, 2021 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2021, and to provide an operational update.
globenewswire
Thu 11:00
CMRX US
Can Teladoc Health Stock Start Climbing Again?
Slowing growth in the face of exploding competition for digital health services should have investors more than a little concerned.
fool
Thu 10:47
TDOC US
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
SHANGHAI, July 29, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced...
prnewswire:443
Thu 10:37
IMMU US
Why Prologis Is Firing on All Cylinders
Companies are working overtime to rebuild inventories, and this logistics-focused REIT has been a beneficiary.
fool
Thu 10:31
PLD US
: Canadian Pacific Railway stock price target cut to $80 from $108 at Cowen
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
marketwatch
Thu 10:23
CP US